Summary Epidemiological studies suggest that childhood common acute lymphoblastic leukaemia (c-ALL) may be the rare outcome of early post-natal infection with a common infectious agent. One of the factors that may determine whether a child succumbs to c-ALL is how it responds to the candidate infection. Since immune responses to infection are under the partial control of (human leucocyte antigen) HLA genes, an association between an HLA allele and c-ALL could provide support for an infectious aetiology. To Gly26, His30, Val57, encoding motifs in c-ALL compared with controls. Since these amino acids are not restricted to DQBI*0501, our results suggest that, as with DPBI, the increased risk of c-ALL associated with DQBI is determined by specific amino acid encoding motifs rather than by an individual allele. These results also suggest that HLAassociated susceptibility to c-ALL may not be restricted to the region bounded by DPBI and DQBI.
Childhood acute lymphoblastic leukaemia (ALL) is the most frequently occurring leukaemia among children of the developed countries (Breslow and Langholz, 1983; Parkin et al., 1988; Linet and Devesa, 1991) . A unique feature of ALL in white Caucasian children is the peak number of cases that occurs between the ages of 2 and 5 years (Stewart, 1961; Parkin et al., 1988; Linet and Devesa, 1991) . This first appeared in the UK as a mortality peak after 1920 (Court Brown and Doll, 1961) , and has remained to the present as an incidence peak, despite a marked reduction in mortality in the past 3 decades. Immunophenotyping has shown that this early peak is almost entirely due to the B-cell precursor form of common ALL (c-ALL) (Greaves, Pegram and Chan, 1985) . Suggestions that the c-ALL peak was unmasked following a decline in pre-emptive childhood mortality from infectious disease between the early 1900s and 1940 (Stewart and Kneale, 1969; Kneale, 1971) have been questioned by Greaves et al. (1991) on the grounds that no similar increase in other subtypes of childhood acute leukaemia has been seen.
The role of infection in the aetiology of childhood ALL has recently been re-examined in relation to its cell biology, the timing of post-natal infection (Greaves and Alexander, 1993) and population mixing (Kinlen et al., 1990) , and has suggested that childhood c-ALL may be the rare outcome of a common but unidentified neonatal infection. This poses questions about the contribution of potentially rate-limiting host factors such as genetic susceptibility (Taylor, 1994) . In order to determine whether these could involve immune response genes, we previously analysed the frequency of HLA -DPBI alleles in c-ALL, and found an increased risk in children with HLA-DPBI*0201 [relative risk (RR) 2.1-2.9] (Taylor et al., 1995) .
To try to define the physical limit of genetic susceptibility within the HLA region, we have now typed the same cohort of children for alleles at the HLA-DQBI locus. This is a related HLA class II gene approximately 420 kb telomeric to DPBI (Trowsdale and Campbell, 1992) . DQBI alleles are associated with susceptibility and resistance to several malignant and non-malignant diseases notably adult T-ALL (Uno et al., 1988) , cervical intraepithelial neoplasia and human papilloma virus (HPV) (Apple et al., 1994) , type 1 (insulin-dependent) dibetes mellitus (Todd, Bell and McDevitt, 1987) and melanoma (Lee et al., 1994) . We report that children who have DQBI*0501 are at increased risk of c-ALL, and that this does not appear to be in linkage disequilibrium with DPBJ*0201. We also find that as with DPBI, the increased risk associated with DQBI is strongest in relation to key amino acid motifs rather than with individual alleles.
Materials and methods Patients and controls
The patients in this study comprise the same cohort as that described previously (Taylor et al., 1995) and consists of 62 children (one child from the previous study is excluded) with c-ALL treated at a single centre (Royal Manchester Children's Hospital) Genomic DNA was extracted from fresh or frozen blood samples using established methods (Blin and Stafford, 1976) , and an exon 2 fragment of DQB1 amplified in the polymerase chain reaction (PCR; Erlich and Arnheim, 1992) using the oligonucleotide primers depicted in Table I Single-strand conformation polv morphism (SSCP) typing DQBI alleles were detected using the SSCP method described by Orita et al. (1989) , modified for HLA-DQBI typing as described by Lo et al. (1992) and Summers et al. (1992) . For this, 15 p1 of each PCR product was mixed with 2 p1 of loading dye (0.5% bromophenol blue, 0.5% xylene cyanol in deionised formamide), and heated to 95CC for 10 min to Table I. denature the DNA and reduce the sample volume to 4-5 p1. The samples were loaded onto non-denaturing polyacrylamide gels (PAGs) in a water-cooled vertical mimn-electrophoresis unit (Cambridge Electrophoresis, Cambridge, UK). SSCP conditions for all group-specific PCR products were the same, including the ratio of acrylamide-methylbisacrylamide (39:1), which was prepared from stock Easigel mix (Scotlab, Strathclyde, UK) and solid acrylamide (BDH, Lutterworth, UK). SSCP gels were run using 0.5X TBE and 0.8 mm spacers, at 9 mA constant current. SSCP band patterns were visualised using silver staining (Qiagen, Dusseldorf, Germany) following the manufacturer's instructions and photographed using a 35 mm SLR camera without filters and Agfa Ortho film.
Data analysis DQBI allele frequencies in c-ALLs and controls were calculated as percentages of total alleles. Phenotype frequencies were determined as the percentage of test subjects with a given allele in either heterozygous or homozygous form. Genotype frequencies were obtained by calculating the proportion of individuals with combinations of two alleles. Relative risks (RRs) were obtained by the cross-product odds ratio method, and these were tested for significance using 2 x 2 (x2) contingency analysis using SIMFIT. Since this study was used for hypothesis generation, no correction for the number of alleles tested has been applied.
Resuls DQB1 molecular typing
In preliminary studies to optimise DQBI molecular typing, we used generic primers obtained from the British Society for Histocompatibility and Immunogenetics (BSHI) to amplify exon 2 from genomic template DNA, and BSHI-derived sequence specific oligonucleotide (SSO) probes to detect specific alleles. However, in our hands, we were unable to distinguish certain DQBI alleles using this system. We therefore designed a set of nine primers as shown in Table   I and Figure 1 , which we used in various combinations to amplify groups of alleles, and SSCP analysis to distinguish the alleles within each group. Using this method we were also able to confirm and clarify DQBI allele assignments obtained on HLA homozygous and heterozygous test cells typed with genenc prmers and SSO probes. All pairs of group-specific primers were found to amplify in the predicted manner according to Table I . No amplification of other allelic groups was obtained, and it was not necessary to introduce deliberate mismatches into the primer sequences to improve speficity.
The results in Figure 2 show SSCP band patterns obtained with the DQBI 02/03 group-specific primers on homozygous and heterozygous cells. They are distinct enough to allow alleles to be assigned in heterozygotes. No DNA was available for the following rare alleles: DQB1*0304, *0605-*0608, but these alleles would have been amplified by our group-specific primers and may give distinct bands. for which there is borderline significance between c-ALL and controls. *P-value.
DQB1 allele frequency in childhood c-ALL Details of the children with c-ALL who were typed for DQBJ in this study are given in a previous paper (Taylor et al., 1995) . Briefly, 62 children with a confirmed diagnosis of c-ALL, consisting of 36 boys and 26 girls (M/F 1.42:1) with a mean age of 5.6 years and age range of 1 -13 years constituted the patient cohort. About one-third of the girls, but nearly half of the boys were diagnosed at 3-4 years of age. Eight of the 62 children with c-ALL were from ethnic minorities, mainly of Asian origin. The present cohort of cALLs comprises 83% of children with ALL ascertained by the Manchester Children's Tumour Registry during the study period. The remainder of the ALLs were excluded from the analysis as being other subtypes, or not confirmed as c-ALL. The control series used here consists of cord blood samples from 76 Caucasian newborn infants delivered in St Mary's between 1990 and 1992. The only subjects excluded from this cohort were preterm and caesarean deliveries and congenital abnormalities. A total of 14 DQBI alleles were identified by SSCP typing of the patient and control groups and of these, 12 alleles were detected in the c-ALLs and ten in the controls. Alleles missing both from patients and controls included *0401 and *0504, whereas *0502 and *0503 were absent from the control series only. A comparison of allele frequencies (Table II) shows a deficit of DQBI*0201 in c-ALLs compared with the controls (c-ALL, 24.2% vs controls, 37.5%), but an excess of *0501 in c-ALLs (c-ALLs, 16.9% vs controls, 9.2%). There is no difference in *0602 frequency in c-ALL and controls, but there is an excess of the combined *0601, *0603 and *0604 alleles in c-ALLs (c-ALLs, 17% vs controls, 9.3%). In addition, the combined frequency of *0302 and *0303 in c-ALL is about half that in the controls (c-ALLs, 7.2% vs controls, 15.1%).
The deficit of *0201 and excess of *0501 alleles in c-ALL is seen more informatively in the phenotype frequency analysis (Table II) Since there are nearly 50% more boys than girls in our c-ALL cohort, we examined whether there might be a Genotype frequencies in c-ALLs and infant controls are compared in Table IV . The most striking difference is the percentage homozygosity (c-ALL, 19.3% vs infants, 42%, P=0.0016). This is largely the result of a marked difference in the frequency of *0201 homozygotes (c-ALL vs infants, 4.8% vs 19.7%). However, the cumulative frequency of non-*0201 homozygotes is also less in c-ALL than it is in the controls (c-ALLs, 14.5% vs controls, 22.3%). Cumulative frequencies of certain heterozygotes, such as *0501/*0201 and *0501/*0301 show quite marked differences (c-ALL, 16.2% vs controls, 6.5%).
It is possible that the increased risk of c-ALL associated with DQBI*0501 could be due to linkage disequilibrium with DPBI*0201, the allele previously shown to be associated with an increased risk of c-ALL in the same cohort (Taylor et al., 1995) . When we analysed the frequency of patients with both alleles, however ( Table V) we found that only 3 of the 62 children with c-ALL typed for DPBI*0201 and DQBI*0501, 29 had neither allele and 15 each had either DPBI*0201 or DQBI*0501. Although there is no significant difference in the frequency of c-ALLs and controls with both alleles or DPBI*0201 alone, the increased frequency of c-ALLs with DQBI*0501 but lacking DPBI*0201 is borderline, and there is a significant decrease in patients with neither allele compared with controls. Taking the cumulative frequency of c-ALLs with one or both candidate susceptibility alleles in comparison with the controls (c-ALLs, 53% vs controls, 29%), the combined RR is 2.76 (P=0.0076).
The DQBJ phenotype analysis shown in Table II shows that frequency of c-ALL children with alleles other than DQBI*0501 is also increased. It is possible that this is owing to associations with amino acids common to more than one allele, as we found for DPBJ. We therefore analysed the DQBJ data by calculating the frequency of selected exon 2 encoded amino acids in the patient and control groups. Amino acids at seven positions were compared (Table VI) , of which three (positions 26, 30 and 57) consist of 3-4 single amino acids, and four positions (13-14, 66-67, 70-71, 86-87) other HLA or non-HLA gene, we carried out further molecular studies on the same cohort to try to define the physical limit of susceptibility to c-ALL in the HLA region. The results reported here show that the risk in children who type for the DQBJ*05 allele series is similar to that for DPB1*0201. More importantly, this does not seem to be due to linkage disequilibrium between DPB1*0201 and DQBI*0501, since only 3 of the 62 patients typed for both alleles. Lack of linkage disequilibrium between DPBI*0201 and DQBI*0501 is supported by other studies (Baisch and Capra, 1993 If genetic susceptibility to c-ALL is conferred by DQBI*05 it suggests some degree of specificity in the interaction with an environmental co-factor. Since there is no evidence from our studies so far that DPBI or DQBI alleles in childhood c-ALL are mutated in the germ line, we assume that the increased risk is conferred by the normal allele itself. This raises the question as to why a relatively common HLA allele should increase the risk of a previously lethal childhood disease such as c-ALL, a clear selective disadvantage to the allele. We previously suggested in the context of DPBI that one explanation for this could be that since HLA alleles are neither necessary nor sufficient to cause leukaemia they may confer protection to some numerically more important infectious agent. Thus, c-ALL high-risk HLA alleles might be less effective in protecting against a leukaemogenic infection caused by molecular mimicry of the susceptibility allele by the infectious agent, but be effective against some other infection. Since the transformation of pre-B progenitor cells into c-ALL requires at least two mutations, it seems unlikely that HLA alleles determine whether a fetus will succumb to an in utero infection. This might be expected to be associated with birth abnormalities in children with leukaemia.
A different interpretation is suggested by the Greaves hypothesis (Greaves and Alexander, 1993) . This postulates that the chance of a second mutation in a preleukaemic pre-B progenitor population is promoted by post-natal infectioninduced cell division. HLA alleles associated with a risk of c-ALL might in this case be the target of, or induce, the immunostimulatory signals which lead to the increased division of the pre-leukaemic population. If an infectious agent contained immunogenic peptides capable of binding to alleles at more than one HLA class II locus, this might maximise immune recognition but also enhance pre-B stimulation. Such a phenomenon might explain the apparent independence of DPBI-and DQBI-associated susceptibility to c-ALL.
We found a difference in the percentage of boys and girls with DQBI*0501 (RRM:F, 2.92), and DQB1*0602 (RRM:F, 0.24). This sex difference in the frequency of a susceptibility allele was absent in our previous analysis of DPBI (Taylor et al., 1995) . One explanation for the sex difference could be that there are subtle male -female differences in genetic susceptibility to immune-associated disease as previously suggested (Purtilo, 1979) . Since there is an excess of males to female with c-ALL in our series, it is possible that Xlinked immunoregulatory genes influence the ability of males and females to respond to HLA-associated immunogenic peptides. Genotype analysis revealed a higher frequency of DQBI*0201 homozygosity in the controls than in the patients. We can exclude typing artifact due to the misidentification of heterozygotes as homozygotes as both series were typed at the same time, using the same reagents and techniques. We can also exclude increased HLA homozygosity due to consanguineous ethnic minority parents, since we excluded Asian infants from the control series. The result suggests that *0201 homozygosity may have a protective effect in c-ALL. It is of interest to note that none of the amino acid sequence motifs found in *0501, or any of the other alleles associated with an increased risk of c-ALL is also found in *0201. More specifically, the serine residue at position 30, and arginine-lysine at positions 70-71 of *0201, both differ from the motifs associated with DQBI susceptibility to c-ALL, and may be considered as conferring protection.
The amino-acid motifs associated with an increased risk of c-ALL include glycine26, histidine30, valine 5 and glutamic acid66-valine67. Of the four motifs at position 57, aspartic acid (Asp57) is present in only 48% of children with c-ALL compared with 64% of infant controls, and is negatively associated with c-ALL. It has been known for some time that Asp57 confers resistance to insulin-dependent diabetes (Todd et al., 1987; Morel et al., 1988; Tosi et al., 1994) , although the presence or absence of this motif is not sufficient to account for inherited susceptibility (Thomson et al., 1988; Kockum et al., 1993) . Although there are few similarities between c-ALL and IDDM other than their occurrence in childhood, the possibility that a common infectious agent, or similar immunoregulatory defect with a different outcome is involved would repay further study.
